Literature DB >> 828833

Purified and inactivated human hepatitis B vaccine: progress report.

M R Hilleman, E B Buynak, R R Roehm, A A Tytell, A U Bertland, G P Lampson.   

Abstract

Developments leading to the preparation and testing for safety and potency of a highly purified inactivated preparation of hepatitis B surface antigen are descirbed. Protective efficacy studies in chimps of a lot of the inactivated hepatitis B vaccine are currently and suitable for clinical trials in man.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 828833     DOI： 10.1097/00000441-197509000-00025

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  25 in total

Review 1.  Viral hepatitis: past and future of HBV and HDV.

Authors:  Emmanuel Thomas; Masato Yoneda; Eugene R Schiff
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

Review 2.  The chimpanzee model for hepatitis B virus infection.

Authors:  Stefan F Wieland
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

3.  The WHO programme for virus diseases in relation to recent trends in medical virology.

Authors:  P Brès
Journal:  Experientia       Date:  1977-01-15

4.  Vaccine against hepatitis B--18 months prevention in a high risk setting.

Authors:  P Maupas; A Goudeau; P Coursaget; J Drucker; P Bagros; S Baudin; N Geslin
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

Review 5.  The hepatitis B virus and its DNA polymerase: the prototype three-D virus.

Authors:  S Z Hirschman
Journal:  Mol Cell Biochem       Date:  1979-07-15       Impact factor: 3.396

Review 6.  Recent advances in the identification of hepatitis viruses.

Authors:  J L Dienstag; R H Purcell
Journal:  Postgrad Med J       Date:  1977-07       Impact factor: 2.401

7.  Proteins of hepatitis B surface antigen.

Authors:  J W Shih; J L Gerin
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

Review 8.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

9.  Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.

Authors:  A M Prince; H Ikram; T P Hopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

Review 10.  Advances in therapeutics for chronic hepatitis B.

Authors:  Ninghan Yang; Antonio Bertoletti
Journal:  Hepatol Int       Date:  2015-09-12       Impact factor: 6.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.